4 unknown, 3 completed, 1 not yet recruiting. 8 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Unknown 4, Completed 3, Not yet recruiting 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Atorvastatin 20mg: new trials by email Literature Review of Atorvastatin 20mg trials Research Report on Atorvastatin 20mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study Atorvastatin 20mg, Placebo - Graves' Orbitopathy | Phase 3 | Not yet recruiting | University of Pisa | 102 | 2024-01-01 | 2023-03-15 |
| Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis Allopurinol 300 MG, Atorvastatin 20mg, Placebo - Cirrhosis, Hepatic Encephalopathy | Phase 2 / Phase 3 | Completed | Tanta University | 150 | 2022-11-15 | 2026-08-11 |
| Statin Impact on Hepatic Decompensation Atorvastatin 20mg, Placebo - Quality of Life, the Incidence of Whole Complications Resultant From Decompensated Liver | Phase 2 / Phase 3 | Completed | Tanta University | 100 | 2022-06-15 | 2026-09-14 |
| Atorvastatin in Management of Newly Diagnosed ITP Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone - Immune Thrombocytopenia, Purpura, Thrombocytopenic | Phase 2 / Phase 3 | Unknown | Shandong University | 30 | 2021-11-01 | 2021-09-05 |
| Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 intermediate dose Enoxaparin/ unfractionated heparin, standard prophylactic dose Enoxaparin/ unfractionated heparin, Atorvastatin 20mg - Covid19 | Phase 3 | Completed | Rajaie Cardiovascular Medical and Research Center | 600 | 2020-07-30 | 2021-08-17 |
| Efficacy of Atorvastatin in Chronic Subdural Haematoma Atorvastatin 20mg, Placebos - Chronic Subdural Hematoma | Phase 3 | Unknown | Chinese University of Hong Kong | 690 | 2020-01-09 | 2021-11-22 |
| Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia Atorvastatin 20mg, Omega-3-acids ethylesters 90 4g, Placebo(Omega-3-acids ethylesters 90) - Hyperlipidemia, Familial Combined | Phase 3 | Unknown | Kuhnil Pharmaceutical Co., Ltd. | 80 | 2014-01-01 | 2014-03-20 |
| Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin Atorvastatin 20mg, Fenofibrate 160mg, Placebo (Fenofibrate 160 mg) - Mixed Hyperlipidemia | Phase 3 | Unknown | Chong Kun Dang Pharmaceutical | 476 | 2013-12-01 | 2015-02-04 |
Ascites (1) · COVID-19 (1) · Fibrosis (1) · Graves Ophthalmopathy (1) · Hematoma, Subdural, Chronic (1) · Hepatic Encephalopathy (1) · Hepatorenal Syndrome (1) · Hyperlipidemia, Familial Combined (1) · Hyperlipoproteinemia Type II (1) · Purpura, Thrombocytopenic (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Varicose Veins (1)
Tanta University (2) · Chinese University of Hong Kong (1) · Chong Kun Dang Pharmaceutical (1) · Kuhnil Pharmaceutical Co., Ltd. (1) · Rajaie Cardiovascular Medical and Research Center (1) · Shandong University (1) · University of Pisa (1)
Egypt (2) · South Korea (2) · China (1) · Hong Kong (1) · Iran (1) · Italy (1)
Behnood Bikdeli, MD, MS (1) · Hee Kyoung Cheon, Ph.D. (1) · Hong Seog Seo, Ph.D. (1) · Mi-Seung Shin, Ph.D (1) · Ming Hou, Dr (1) · MoonKyu Lee, M.D., Ph.D. (1) · Parham Sadeghipour, MD (1) · Sang-Ho Jo, Ph.d. (1) · Wai Sang Poon, MBChB-Glasg FRCSEd FHKAM-Surg (1)
PMID 32992075, PMID 33734299, PMID 34996756, PMID 35165110, PMID 35244208, PMID 36944357, PMID 41865069